During the past decade, Dr. Nagy Laszlo Kardiologiai Maganrendeles conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Nagy Laszlo Kardiologiai Maganrendeles" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Nagy Laszlo Kardiologiai Maganrendeles" are "Heart Failure" (2 trials), "Dyslipidemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Dr. Nagy Laszlo Kardiologiai Maganrendeles" in a lesser frequency.

Most popular intervention types in "Dr. Nagy Laszlo Kardiologiai Maganrendeles" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Nagy Laszlo Kardiologiai Maganrendeles" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dr. Nagy Laszlo Kardiologiai Maganrendeles". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr. Nagy Laszlo Kardiologiai Maganrendeles, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Nagy Laszlo Kardiologiai Maganrendeles, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".